Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association

Citation:

Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, Schoenthaler A, Houston Miller N, Hyman DJ. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension 2022;79(1):e1-e14.
PDF274 KB

Date Published:

Jan

Abstract:

The widespread treatment of hypertension and resultant improvement in blood pressure have been major contributors to the dramatic age-specific decline in heart disease and stroke. Despite this progress, a persistent gap remains between stated public health targets and achieved blood pressure control rates. Many factors may be important contributors to the gap between population hypertension control goals and currently observed control levels. Among them is the extent to which patients adhere to prescribed treatment. The goal of this scientific statement is to summarize the current state of knowledge of the contribution of medication nonadherence to the national prevalence of poor blood pressure control, methods for measuring medication adherence and their associated challenges, risk factors for antihypertensive medication nonadherence, and strategies for improving adherence to antihypertensive medications at both the individual and health system levels.

Notes:

1524-4563Choudhry, Niteesh KKronish, Ian MVongpatanasin, WanpenFerdinand, Keith CPavlik, Valory NEgan, Brent MSchoenthaler, AntoinetteHouston Miller, NancyHyman, David JAmerican Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical CardiologyJournal ArticleUnited States2021/10/08Hypertension. 2022 Jan;79(1):e1-e14. doi: 10.1161/HYP.0000000000000203. Epub 2021 Oct 7.

Last updated on 01/20/2022